Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Sung Min Kim, Yu Jin Jung et al.|JAMA Neurology|2024Cited by 26
Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGADJae‐Won Hyun, Ho Jin Kim, Hye Lim Lee et al.|Multiple Sclerosis Journal|2021Cited by 22
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu‐Hyun Kim, Ho Jin Kim, Ju‐Hong Min et al.|Journal of Clinical Neurology|2025Cited by 11
Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre studyKi Hoon Kim, Ho Jin Kim, Yeon Hak Chung et al.|Journal of Neurology Neurosurgery & Psychiatry|2024Cited by 8
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou‐Ri Kang, Hyunjin Ju, Ki Hoon Kim et al.|Multiple Sclerosis Journal|2025Cited by 5